Evidence map›Paper›PMID 39282945›Full record

ArticleBrain : a journal of neurology2025

Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson's disease.

Alex I Wiesman, Victoria Madge, Edward A Fon, Alain Dagher, D Louis Collins, Sylvain Baillet, PREVENT-AD Research Group and Quebec Parkinson Network

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. The Noradrenergic Brain in Parkinson's Disease.Current neurology and neuroscience reports · 2026
    Review
  5. Review
  6. Review
  7. The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyond.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  8. Article
  9. Cortical Effects of Dopamine Replacement Account for Clinical Response Variability in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alex I WiesmanMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.ORCID 0000-0003-0917-1570
Victoria MadgeMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.
Edward A FonMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.ORCID 0000-0002-5520-6239
Alain DagherMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.ORCID 0000-0002-0945-5779
D Louis CollinsMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.ORCID 0000-0002-8432-7021
Sylvain BailletMontreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4.
PREVENT-AD Research Group and Quebec Parkinson Network

Funding

BrainStorm: Highly Extensible Software for Advanced Electrophysiology and MEG/EEG ImagingR01EB026299 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LEAHY, RICHARD M · 2018 to 2025
$5.4M
CIHR BPF-186555Douglas Hospital Research Centre FoundationHealthy Brains for Healthy Lives initiative of McGill UniversityMcGill University Faculty of MedicineNatural Science and Engineering Research Council of CanadaNeural Dynamics of Brain Systems R01-EB026299NIBIB NIH HHS R01 EB026299Quebec Parkinson NetworkUnited States National Institutes of HealthWeston Family Foundation RGPIN-2020-06889
6 · The paper itself

Abstract

Parkinson's disease (PD) is marked by the death of neuromelanin-rich dopaminergic and noradrenergic cells in the substantia nigra (SN) and the locus coeruleus (LC), respectively, resulting in motor and cognitive impairments. Although SN dopamine dysfunction has clear neurophysiological effects, the association of reduced LC norepinephrine signalling with brain activity in PD remains to be established. We used neuromelanin-sensitive T1-weighted MRI (PD, n = 58; healthy control, n = 27) and task-free magnetoencephalography (PD, n = 58; healthy control, n = 65) to identify neuropathophysiological factors related to the degeneration of the LC and SN in patients with PD. We found pathological increases in rhythmic alpha-band (8-12 Hz) activity in patients with decreased LC neuromelanin, which were more strongly associated in patients with worse attentional impairments. This negative alpha-band-LC neuromelanin relationship is strongest in fronto-motor cortices, where alpha-band activity is inversely related to attention scores. Using neurochemical co-localization analyses with normative atlases of neurotransmitter transporters, we also show that this effect is more pronounced in regions with high densities of norepinephrine transporters. These observations support a noradrenergic association between LC integrity and alpha-band activity. Our data also show that rhythmic beta-band (15-29 Hz) activity in the left somatomotor cortex decreases with lower levels of SN neuromelanin; the same regions where beta activity reflects axial motor symptoms. Together, our findings clarify the association of well-documented alterations of rhythmic neurophysiology in PD with cortical and subcortical neurochemical systems. Specifically, attention-related alpha-band activity is related to dysfunction of the noradrenergic system, and beta activity with relevance to motor impairments reflects dopaminergic dysfunction.

Indexed as

Cerebral CortexMelaninsParkinson DiseaseAgedAlpha RhythmFemaleHumansLocus CoeruleusMagnetic Resonance ImagingMagnetoencephalographyMaleMiddle AgedSubstantia NigraMelaninsneuromelanincortical rhythmslocus coeruleusmagnetoencephalographyneuromelaninParkinson’s diseasesubstantia nigra

Identifiers

PMID39282945
PMCPMC11884654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.